SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-18-006855
Filing Date
2018-02-06
Accepted
2018-02-06 16:24:35
Documents
1
Period of Report
2018-02-02

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3899
  Complete submission text file 0001104659-18-006855.txt   5288
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Issuer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address
Bergstrom Donald A (Reporting) CIK: 0001709772 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38129 | Film No.: 18577890